Literature DB >> 34062068

Analysis of sex difference in the tubular reabsorption of lithium in rats.

Y Uwai1, R Yamaguchi, T Nabekura.   

Abstract

Lithium is used in the treatment of bipolar disorder. We previously demonstrated that two types of transporters mediate the tubular reabsorption of lithium in rats, and suggested that sodium-dependent phosphate transporters play a role in lithium reabsorption with high affinity. In the present study, we examined sex differences in lithium reabsorption in rats. When lithium chloride was infused at 60 µg/min, creatinine clearance and the renal clearance of lithium were lower, and the plasma concentration of lithium was higher in female rats. These values reflected the higher fractional reabsorption of lithium in female rats. In rats infused with lithium chloride at 6 µg/min, the pharmacokinetic parameters of lithium examined were all similar in both sexes. The fractional reabsorption of lithium was decreased by foscarnet, a representative inhibitor of sodium-dependent phosphate transporters, in male and female rats when lithium chloride was infused at the low rate. Among the candidate transporters mediating lithium reabsorption examined herein, the mRNA expression of only PiT2, a sodium-dependent phosphate transporter, exhibited sexual dimorphism. The present results demonstrated sex differences in the tubular reabsorption of lithium with low affinity in rats.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34062068      PMCID: PMC8820543          DOI: 10.33549/physiolres.934568

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  13 in total

Review 1.  Lithium intoxication.

Authors:  R T Timmer; J M Sands
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

2.  Nonlinear disposition of lithium in rats and saturation of its tubular reabsorption by the sodium-phosphate cotransporter as a cause.

Authors:  Yuichi Uwai; Tatsuya Kawasaki; Tomohiro Nabekura
Journal:  Biopharm Drug Dispos       Date:  2018-01-12       Impact factor: 1.627

3.  Contribution of NHE3 and dietary phosphate to lithium pharmacokinetics.

Authors:  Linto Thomas; Jianxiang Xue; Jessica A Dominguez Rieg; Timo Rieg
Journal:  Eur J Pharm Sci       Date:  2018-11-09       Impact factor: 4.384

4.  Insights into the biochemical mechanism of maleic acid-induced Fanconi syndrome.

Authors:  S Eiam-ong; M Spohn; N A Kurtzman; S Sabatini
Journal:  Kidney Int       Date:  1995-11       Impact factor: 10.612

5.  Evans blue is a specific antagonist of the human epithelial Na+ channel delta-subunit.

Authors:  Hisao Yamamura; Shinya Ugawa; Takashi Ueda; Shoichi Shimada
Journal:  J Pharmacol Exp Ther       Date:  2005-08-17       Impact factor: 4.030

6.  Sodium-phosphate cotransporter mediates reabsorption of lithium in rat kidney.

Authors:  Yuichi Uwai; Ryosuke Arima; Chihiro Takatsu; Ryo Furuta; Tatsuya Kawasaki; Tomohiro Nabekura
Journal:  Pharmacol Res       Date:  2014-07-02       Impact factor: 7.658

Review 7.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 8.  Drug Interactions with Lithium: An Update.

Authors:  Patrick R Finley
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

9.  Amiloride-sensitive lithium reabsorption in rats: a micropuncture study.

Authors:  R Fransen; W H Boer; P Boer; H A Koomans
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

10.  Potent Inhibition of Biphasic Tubular Reabsorption of Lithium by Acetazolamide and Foscarnet in Rats.

Authors:  Y Uwai; R Kondo; T Suzuki; T Kawasaki; T Nabekura
Journal:  Physiol Res       Date:  2020-06-25       Impact factor: 1.881

View more
  1 in total

1.  Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats.

Authors:  Rachel Shvartsur; Galila Agam; Sarit Uzzan; Abed N Azab
Journal:  Pharmaceutics       Date:  2022-04-20       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.